Cost-Consequence Analysis of Colon Cancer Screening among Patients with Long-Standing Ulcerative Colitis: 11 Years' Experience of Saudi Population.

Publication Year: 2023

DOI:
10.1016/j.jsps.2023.101883

PMCID:
PMC10711162

PMID:
38088946

Journal Information

Full Title: Saudi Pharm J

Abbreviation: Saudi Pharm J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"The authors acknowledge the financial support received from the Researchers Supporting Project number (RSP2023R16), King Saud University, Riyadh, Saudi Arabia. The funding body had no. role in the design of this study, its execution, analyses, interpretation of the data, or decision to submit results."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025